D
Grace Therapeutics, Inc. GRCE
$3.00 -$0.13-4.15% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 25.56% 65.52% 71.18% 72.70% 69.71%
Total Depreciation and Amortization -36.36% -66.67% -81.48% 113.89% -91.13%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -417.78% -106.66% -109.35% -99.59% -93.17%
Change in Net Operating Assets 126.72% 168.18% 206.49% 386.76% -807.18%
Cash from Operations -20.85% -3.44% 23.28% 42.08% 22.50%
Capital Expenditure -- -175.00% -175.00% -120.00% -29.41%
Sale of Property, Plant, and Equipment -- -99.09% -99.09% -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -100.00% 522.72% 100.00% 100.00% -99.89%
Cash from Investing -100.00% 550.96% -120.79% 184.76% -99.21%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 99.43% -97.80% -97.80% 6,800.00% 2,374.01%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -496.91% -- -- -- --
Cash from Financing 90.68% -100.00% -100.00% 6,651.38% 2,320.72%
Foreign Exchange rate Adjustments -- -- -- 109.52% 100.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 82.09% 2.68% -49.16% 86.63% -97.65%